The upregulation of the TGF-β-induced TGFBI in BMSCs (Table S6) supports the hypothesis that ColX may originate from “activated,” dysregulated bone marrow-derived mesenchymal cells which infiltrate breast and pancreatic tumors. The gene discussed is TGFB1; the disease is pancreatic neoplasm.